PQQ is a redox cofactor that exists in various foods, including fermented soybeans, green peppers, and kiwi fruit. Unlike many vitamins and nutrients, PQQ is not as widely known, yet its potential therapeutic benefits are becoming increasingly appreciated. Research has suggested that PQQ possesses antioxidant properties, which allow it to neutralize free radicals and reduce oxidative stress—an imbalance that can damage cells and lead to various health issues, including mitochondrial dysfunction.
Another notable benefit of PQQ is its potential role in cardiovascular health. PQQ has been shown to have antioxidant properties, which means it can help neutralize free radicals in the body. Excessive free radicals can lead to oxidative stress, a contributing factor in numerous chronic diseases, including heart disease. By reducing oxidative stress, PQQ may support heart health and improve overall cardiovascular function. Some studies have indicated that PQQ might also help lower LDL cholesterol levels, which is often referred to as “bad” cholesterol, providing yet another reason to consider its inclusion in a health regimen.
APIs are crucial in the development of safe and effective medications. They undergo rigorous testing for efficacy, safety, and stability before being approved for use. The process of developing an API involves several stages, including discovery, preclinical testing, clinical trials, and regulatory approval. Once an API passes these stages, it can be formulated into a drug product, which may include excipients or inactive ingredients that aid in the delivery of the active substance.